3 U.S. Cannabis Stocks for 2020 and Beyond

With a growing acceptance of cannabis for medicinal and recreational use across the U.S., many new companies have launched over the past two years. What used to be small, undercover operations to supply an illegal product has turned into a flourishing industry. Big money is at stake for both companies and investors, racing to capture this huge, untapped market. So,…

Read More

Cannabis Alert: No Pot Stock Has More Upside Than This Company

Pot stocks soared in 2018. Many companies doubled or tripled in value. Last year was a different story, however. Most cannabis stocks fell by at least 50%. More than $10 billion in market value was erased. What will 2020 bring? Following the bear market of 2019, some pot stocks are primed for a rebound. Valuations are the lowest they’ve ever…

Read More

Why This Is the Best Cannabis Stock in Canada 

The cannabis industry hasn’t been able to catch a break. After touching record highs just over a year ago, the industry has been in a prolonged bear market.  Since peaking in March of 2019, the Canadian Marijuana Index has lost 74% of its value. The recent downturn has wiped out most of the industry’s goodwill and the Index is now…

Read More

Why the Hexo (TSX:HEXO) Stock Price Fell 19.8% in January

Cannabis stocks like Hexo (TSX:HEXO)(NYSE:HEXO) had their heads handed to them in January once again, as the downward spiral continues. When a bubble bursts, it falls hard, and Hexo’s stock price is a prime example of this. Down 19.8% in January, 75.6% in the last year and 85.1% from its highs, Hexo stock still carries too much risk and uncertainty for…

Read More

Why the Aphria (APHA) Stock Price Fell 8.7% in January

Cannabis stocks have certainly taken a beating in the last year. For some, this beating continues into 2020. Aphria Inc. (TSX:APHA)(NYSE:APHA) stock price fell once again in January, as other cannabis stocks have benefitted from investors seeking a bargain in this potentially lucrative industry. From Aphria stock target price raises to EU certification to analyst upgrades, recent Aphria stock news…

Read More

Top Cannabis Stocks for 2020

Cannabis stocks are ready for a rebound. After a difficult 2019, valuations have compressed to attractive levels. Demand forecasts, meanwhile, continue to exceed expectations. Cowen Inc, one of the more experienced voices on cannabis, noted in 2016 that global pot sales would rise from $6 billion to $50 billion by 2026. “Cannabis prohibition has been in place for over 80…

Read More

Cannabis May Not Rebound in 2020, but Aphria (TSX:APHA) Could Soar

Many pundits are predicting that after a rough 2019, cannabis stocks will bounce back in 2020. During 2019, the marijuana bubble burst, seeing many cannabis stocks plunge sharply over the course of the year, causing the industry’s largest exchange-traded fund (ETF), ETFMG Alternative Harvest ETF, to lose a whopping 35%, with its largest single holding Canopy Growth shedding the same…

Read More

TFSA Investors: Buy Aphria (TSX:APHA) Stock

Cannabis grower and leading distributor Aphria’s (TSX:APHA)(NYSE:APHA) stock price could continue to surge and outperform industry peers in 2020, and I’m maintaining my positive outlook and reiterating a buy recommendation on this marijuana firm. In a November 2019 post, and while discussing three potential buys for 2020, I likened the stock’s potential payoff to that on a cannabis lottery ticket.…

Read More

Will Aphria (TSX:APHA) Stock Hit Double Digits This Winter?

Aphria (TSX:APHA)(NYSE:APHA) stock is currently trading around $7, far from its 52-week high of $14.37, which was reached on February 4, 2019. The last time Aphria’s share price was in the double digits was on August 6, when the stock traded at a high of $10.05. Like other cannabis stocks, Aphria stock fell in 2019, plunging 11% over the year.…

Read More

2 Massive Growth Catalysts for the Canadian Cannabis Sector

Investors in the Canadian cannabis space have undoubtedly been hit hard of late. The Exchange-Traded Fund (ETF) tracking the sector, Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ) has dipped to near-record lows of late on headwinds related to profitability across the sector, a number of recalls, and issues surrounding the black market and the willingness of Canadians to pay full pop…

Read More